MRP, LLC dba Aquabiliti recalls AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, i

Recalled February 28, 2024 · FDA recall Z-1174-2024 · MRP, LLC

Hazard

The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months. · FDA Class II

Units

3,080,000 syringes

Sold at

US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA.

Description

The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.

Product

AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.

Manufacturer(s)

MRP, LLC dba Aquabiliti

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →